The proportion of participants reporting a minimum of a single adverse event was not influenced by dose, nor was the quantity with a significant adverse event, which was no more than with placebo.on ’Anticonvulsants in acute and Long-term pain’ (Wiffen 2005a). Because pregabalin has long been launched within the last few a long time, with sever